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Deafness Locus DFNB16 Is Located on Chromosome
15q13-q21 within a 5-cM Interval Flanked by
Markers D15S994 and D15S132
To the Editor:
Inherited human deafness has an incidence of ∼1/2,000
births (Cohen and Gorlin 1995). The hearing impair-
ment can be associated with other clinical features as
part of a distinct syndrome, but in most cases (70%) it
is the sole clinical sign (Bergstrom et al. 1971). Auto-
somal recessive transmission accounts for85%of non-
syndromic sensorineural deafness (Cohen and Gorlin
1995). Nonsyndromic autosomal recessive deafness is
clinically homogeneous; in most cases, the hearing loss
has a prelingual onset, involves all the frequencies, is
severe or profound, and is nonprogressive (Van Camp
et al. 1997). However, as expected from the structural
and functional complexity of the inner ear, sensorineural
deafness exhibits a very high genetic heterogeneity.Nine-
teen loci for autosomal recessive hearing loss have been
mapped, to date (Hereditary Hearing Loss home page).
One of these loci, DFNB16, wasmapped to chromosome
15q21-22 by linkage studies of three consanguineous
families from Pakistan, Palestine, and Syria (Campbell
et al. 1997). Analysis of recombinant haplotypes indi-
cated that the locus was in a 20-cM interval delimited
by markers D15S994 and D15S155. Acting on the re-
sults of homozygosity data, Campbell et al. (1997) nar-
rowed the location of DFNB16 to the 15-cM distal part
of the interval, between markers D15S1039 and
D15S155. The pedigree and haplotype analysis of family
S040 (fig. 1) provides evidence against the last conclu-
sion. Our work locates DFNB16 to the proximal 5-cM
part of the interval, between D15S1044 and D15S132.
Informed consent was obtained from all the individ-
uals included in the study. All the family members un-
derwent a clinical examination. Environmental factors
were eliminated as the cause of deafness in all affected
family members. There were no features suggestive of
ophthalmologic, skin, or renal syndromic anomalies.
Conductive hearing loss was ruled out by otoscopic ex-
amination, tympanometry with acoustic reflex testing,
and use of the tuning fork test. Pure-tone audiometry
was performed to test for air conduction (frequencies of
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Table 1
Two-Point LOD Scores between Marker Loci from 15q21 and the
DFNB16 Locus
MARKER
RECOMBINATION FRACTION AT v 
Zmax vmax.00 .01 .05 .10 .20 .30 .40
D15S102  .84 .19 .05 .17 .14 .05 .18 .218
D15S1044  1.82 2.25 2.20 1.77 1.14 .44 2.26 .063
D15S129 2.38 2.34 2.17 1.95 1.48 .96 .38 2.38 .000
D15S994 3.88 3.82 3.53 3.16 2.37 1.50 .57 3.88 .000
D15S514 3.88 3.82 3.53 3.16 2.37 1.50 .57 3.88 .000
D15S780 3.88 3.82 3.53 3.16 2.37 1.50 .57 3.88 .000
D15S222 2.38 2.34 2.17 1.95 1.48 .96 .38 2.38 .000
D15S132  1.82 2.25 2.20 1.77 1.14 .44 2.26 .063
D15S1039  1.82 2.25 2.20 1.76 1.13 .42 2.26 .063
D15S123  .12 1.26 1.52 1.40 .96 .38 1.54 .122
Figure 1 Pedigree and haplotype analysis of family S040. The order of the markers was set by integrating genetic and physical data from
previous studies (Fougerousse et al. 1994; Allamand et al. 1995; Dib et al. 1996; Robinson et al. 1997). However, the relative order of markers
D15S1044 and D15S129, as well as that of markers D15S994 and D15S514, are arbitrary and remain to be established (note that this does
not affect the conclusions of this study). The D15S155 marker mentioned in the text is distal to D15S123 (Campbell et al. 1997). Blackened
symbols represent affected individuals. Haplotypes are represented by bars, with the haplotype associated with deafness blackened to show the
recombinations. A thin line between two bar segments indicates that the marker was not informative for mapping the breakpoint.
125–8,000 Hz) and bone conduction (frequencies of
250–8,000 Hz). The hearing loss is bilateral and sen-
sorineural in the six affected patients. Onset of hearing
loss was in early childhood and was nonprogressive (the
ages of deaf individuals are 35–60 years, and there are
records of audiometry tests performed during their child-
hood). A characteristic audiogram is shown in figure 2.
The hearing impairment involves all the frequencies and
is moderate in the range of 125–1,000 Hz but is severe
in the higher frequencies. Findings from vestibular func-
tion testing were normal, and there were no symptoms
of tinnitus. This phenotype could not be compared with
those of the other families with DFNB16, because their
clinical data have not been reported (Campbell et al.
1997).
To map the deafness locus, we extracted DNA from
blood samples from all members of the family and gen-
otyped it for a set of microsatellite markers located close
to the deafness loci already known (two markers per
locus; Hereditary Hearing Loss home page). PCR was
performed as described elsewhere (del Castillo et al.
1996), but one of the primers was labeled with a fluo-
rescent dye (TET, 6-FAM, or HEX), and amplified alleles
were resolved by capillary electrophoresis in an ABI
Prism 310 Genetic Analyzer (Perkin-Elmer). We per-
formed linkage analysis using the LINKAGE 5.1 soft-
ware package (Lathrop et al. 1985), setting the frequency
of the deafness gene to .0001 and considering marker-
allele frequencies to be equal to each other. Two-point
LOD scores were calculated with MLINK and ILINK
programs (LINKAGE). Extensive alterations of the dis-
ease-gene frequency, or of the allele frequencies of mi-
crosatellite markers, did not significantly change the
LOD scores.
Evidence of linkage to markers D15S1028 and
D15S982, in the 15q21 region near the DFNB16 locus,
was found (all the other deafness loci were excluded).
Genotyping the family for additional markers of this
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Figure 2 Audiogram of patient II-2. Audiograms of other affected individuals in the family were not significantly different. Hearing loss
is bilateral, with a very similar pattern for both ears. For clarity, only results for the right ear are presented. Dots denote air conduction, triangles
denote bone conduction.
region confirmed the linkage. A maximum LOD score
(Zmax) of 3.88 at a recombination fraction (v) of .000
was obtained for markers D15S994, D15S514, and
D15S780 (table 1). The position of the disease locus was
narrowed by haplotype analysis. Three recombinant
chromosomes were identified (fig. 1). Two of them de-
fined the limits for the interval that must contain the
disease locus. In patient II-2, the recombination event,
between D15S1044 and D15S994, located the disease
telomeric to marker D15S1044. In patient II-12, the re-
combination took place between D15S780 and
D15S132, mapping the disease locus centromeric to
marker D15S132.
These mapping data are fully consistent with those
obtained by Campbell and colleagues from the study of
two of their families, which defined the 20-cM interval
between D15S994 and D15S155. Data to narrow this
interval were provided by autozygosity mapping per-
formed on a third family (Campbell et al 1997). How-
ever, the homozygosity region in this family was rela-
tively small (only two markers, D15S123 and
D15S1028, very close together, were in homozygosity in
two affected individuals of that family) (Campbell et al.
1997). If data from this third family are taken into ac-
count, the interval established by Campbell and col-
leagues and the interval defined in our report would not
be overlapping, and we would have defined a novel locus
for autosomal recessive hearing loss. However, because
the evidence for linkage of the third family is weak, we
find it is more likely that there is only one deafness locus
in the region, DFNB16. On the basis of this assumption,
and integrating all the available data, DFNB16 would
be within a genetic interval of 5 cM, between D15S994
(centromeric limit) and D15S132 (telomeric limit).
The DFNB16 critical interval corresponds to a region
that was investigated thoroughly during the search for
a gene responsible for a recessive form of limb-girdle
muscular dystrophy (LGMD2A). As a consequence, a
YAC contig and a transcriptional map of the region,
containing5 known genes and 12 anonymous cDNAs,
are available (Fougerousse et al. 1994; Chiannilkulchai
et al. 1995). Given the functional diversity of the genes
and proteins involved in inherited deafness, no posi-
tional candidate gene can be excluded a priori. Com-
parative mapping is not of help, unfortunately, because
no mouse mutations causing hearing impairment map
to the region homologous to human 15q13-q21. Testing
the expression of positional candidates in the inner ear
should help to identify the gene responsible for auto-
somal recessive hearing impairment at DFNB16.
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Prevalence of Bloom Syndrome Heterozygotes
among Ashkenazi Jews
To the Editor:
Bloom syndrome (MIM 210900) is a condition of in-
trauterine and postnatal growth failure, facial erythema,
immunodeficiency, and early malignancies (German
1995). Death from malignancy typically occurs in the
second or third decade (German 1997). At the cellular
level, mutations in both alleles of the Bloom syndrome
gene (BLM) lead to chromosomal breakage, an excess
number of somatic mutations, and an observed increase
in the frequency of sister chromatid exchange in cultured
cells (German et al. 1996). Among 28 of 29 Ashkenazi
Jewish individuals, a single, noncomplementing muta-
tion has been observed (Ellis et al. 1995). This was
shown to be a deletion of 6 bp, followed by insertion
of 7 bp, leading to a frameshift with premature termi-
nation of the encoded gene product (Ellis et al. 1995).
The finding of linkage disequilibrium of this mutation
with neighboring DNA markers demonstrated that this
unusual mutation had a single genetic origin in the Ash-
kenazi Jewish population ∼400–500 years ago (Ellis et
al. 1994). A 1977 survey of Israeli patients with Bloom
syndrome suggested that 1 in 110 Ashkenazi Jews was
a heterozygote for a mutated BLM gene (German et al.
1977).
A number of autosomal recessive conditions are
known to occur with increased frequency among Ash-
kenazi Jews, including Tay-Sachs disease, cystic fibrosis,
Gaucher disease, Canavan disease, Fanconi anemia com-
plementation group C, Niemann-Pick disease, familial
dysautonomia, and Bloom syndrome (Motulsky 1995).
Early success of Tay-Sachs carrier-screening programs
has led to increased interest in screening for other prev-
alent disorders, and as the genetic basis for these con-
ditions is identified, the new information is used to de-
velop carrier-screening tests (Eng et al. 1997; Kronn et
al. 1998). The recent identification of the gene for Bloom
syndrome provided an opportunity to determine the fre-
quency of heterozygotes in the Ashkenazi Jewish pop-
